MULTIPLE LIPOPOLYSACCHARIDE (LPS) INJECTIONS ALTER INTERLEUKIN 6 (IL-6), IL-7, IL-10 AND IL-6 AND IL-7 RECEPTOR MRNA IN CNS AND SPLEEN

作者：Szot Patricia^*; Franklin Allyn; Figlewicz Dianne P; Beuca Timothy Petru; Bullock Kristin; Hansen Kim; Banks William A; Raskind Murray A; Peskind Elaine R

来源：Neuroscience, 2017, 355: 9-21.

DOI：10.1016/j.neuroscience.2017.04.028

• Neuroinflammation
• LPS
• spleen
• interleukin-6
• interleukin-10
• IL receptor

Neuroinflammation is proposed to be an important component in the development of several central nervous system (CNS) disorders including depression, Alzheimer's disease, Parkinson's disease, and traumatic brain injury. However, exactly how neuroinflammation leads to, or contributes to, these central disorders is unclear. The objective of the study was to examine and compare the expression of mRNAs for interleukin-6 (IL-6), IL-7, IL-10 and the receptors for IL-6 (IL-6R) and IL-7 (IL-7R) using in situ hybridization in discrete brain regions and in the spleen after multiple injections of 3 mg/kg lipopolysaccharide (LPS), a model of neuroinflammation. In the spleen, LPS significantly elevated IL-6 mRNA expression, then IL-10 mRNA, with no effect on IL-7 or IL-7R mRNA, while significantly decreasing IL-6R mRNA expression. In the CNS, LPS administration had the greatest effect on IL-6 and IL-6R mRNA. LPS increased IL-6 mRNA expression only in non neuronal cells throughout the brain, but significantly elevated IL-6R mRNA in neuronal populations, where observed, except the cerebellum. LPS resulted in variable effects on IL-10 mRNA, and had no effect on IL-7 or IL-7R mRNA expression. These studies indicate that LPS-induced neuroinflammation has substantial but variable effects on the regional and cellular patterns of CNS IL-6, IL-7 and IL-10, and for IL-6R and IL-7R mRNA expression. It is apparent that administration of LPS can affect non-neuronal and neuronal cells in the brain. Further research is required to determine how CNS inflammatory changes associated with IL-6, IL-10 and IL-6R could in turn contribute to the development of CNS neurological disorders. Published by Elsevier Ltd on behalf of IBRO.

• 出版日期2017-7-4